| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | United States | 3 | |
| #4 | Australia | 2 | |
| #5 | Canada | 2 | |
| #6 | China | 2 | |
| #7 | Israel | 2 | |
| #8 | Republic of Korea | 2 | |
| #9 | Mexico | 2 | |
| #10 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Medical technology | |
| #4 | Foods and drinks | |
| #5 | Basic materials chemistry |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Therapeutic chemical compounds | |
| #5 | Soaps | |
| #6 | Foods | |
| #7 | Object sterilising |
| # | Name | Total Patents |
|---|---|---|
| #1 | Griessl Martin | 19 |
| #2 | Biebl Manfred | 8 |
| #3 | Martin Griessl | 2 |
| #4 | Manfred Biebl | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2018248060A1 | Engineered Gram-negative endolysins | |
| WO2017203471A1 | Endolysin variant | |
| WO2018100408A1 | Modified peptides |